Deutsche Bank AG is preparing to sell about $3 billion in debt markets for accounting services firm Baker Tilly Advisory Group to refinance private credit loans.
Eli Lilly’s proposed acquisition of AtaiBeckley is “the clearest strategic validation to date” of psychedelics as an emerging pharmaceutical category, according to H.C. Wainwright. The analyst cautioned, however, that the transaction should not be seen as “supporting a uniform re-rating of every psychedelic developer.”
Eighteen companies have gone public this year so far, putting 2026 on pace to record the highest number of IPOs since the pandemic-driven high of 2021.
Poised to become the first company to achieve a regulatory filing for a cell therapy in autoimmune disease, Kyverna Therapeutics is building a pipeline-in-a-product to change the treatment paradigm.
A windfall in corporate profits for the largest banks has led to billions in extra tax revenue for New York City, shrinking the city’s budget shortfalls.
Shakira’s fight with Spain’s tax agency is set to head to the country’s highest court after authorities challenged an earlier ruling in the singer’s case.
Basis, an AI agent platform for accountants that reached a $1.15 billion valuation, debuted a website that provides a tribute to the accounting profession.